Nautilus Biotechnology In...
(NAUT)
undefined
undefined%
At close: undefined
2.00
2.05%
After-hours Dec 13, 2024, 04:26 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | - | - | - | - | - | - |
Cost of Revenue | 5.71M | 3.42M | 2.84M | 2.35M | - | - |
Gross Profit | -5.71M | -3.42M | -2.84M | -2.35M | - | - |
Operating Income | -76.15M | -63.62M | -50.50M | -15.74M | -10.11K | -111.68M |
Interest Income | 12.55M | 5.82M | 329.00K | - | - | - |
Pretax Income | -63.67M | -57.92M | -50.31M | -15.62M | -9.62K | 626.60M |
Net Income | -63.67M | -63.74M | -50.31M | -15.62M | -9.62K | 626.60M |
Selling & General & Admin | 28.90M | 25.95M | 21.15M | 3.31M | 1.62K | 111.68M |
Research & Development | 47.25M | 37.67M | 29.35M | 12.43M | 8.49K | - |
Other Expenses | - | -122.00K | 183.00K | 125.00K | - | - |
Operating Expenses | 76.15M | 63.62M | 50.50M | 15.74M | 9.62K | 111.68M |
Interest Expense | - | 5.82M | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - |
Cost & Expenses | 76.15M | 63.62M | 50.50M | 15.74M | 9.62K | 111.68M |
Income Tax | - | 5.82M | 2.61M | 2.14M | -171.31K | 738.12M |
Shares Outstanding (Basic) | 124.92M | 124.59M | 84.46M | 29.96M | 7.19M | 7.19M |
Shares Outstanding (Diluted) | 124.92M | 124.59M | 84.46M | 29.96M | 7.19M | 7.19M |
EPS (Basic) | -0.51 | -0.51 | -0.6 | -0.52 | -0.00 | 87.18 |
EPS (Diluted) | -0.51 | -0.51 | -0.6 | -0.52 | -0.00 | 87.18 |
EBITDA | -74.30M | -54.51M | -47.47M | -13.27M | -9.56M | 626.60M |
Depreciation & Amortization | 1.85M | 3.42M | 2.84M | 2.35M | 548.00K | 738.28M |